We selected the enzalutamide-resistant 22Rv1 cells to represent ARSI-resistant mCRPC; 22Rv1 cells also have higher SSTR1 expression compared with several other PCa cell lines (69). The gene discussed is SSTR1; the disease is posterior cortical atrophy.